The event the market had been bracing for since June arrived on Thursday, and it was an anticlimax. SpaceX’s first post-IPO lockup expired, making up to 911.5 million insider shares eligible to trade — about 43% more stock than the 638.9 million shares the company floated in its June debut, and roughly $101 billion at current prices. The freely tradable portion of the company went from 4.9% of shares outstanding to 11.8%.
It landed on the worst possible day. On Wednesday the stock fell almost 14% — its second-worst session on record — to close at $108.27, an all-time low, after its first public earnings report showed heavier AI capital spending than analysts expected. Shares then dipped to $105.11 early Thursday, within striking distance of the $104.83 52-week low, before recovering. By early Thursday afternoon in New York the stock was quoted at $110.63, up 2.2% on the session, and Bloomberg described it as steady. On a day the S&P 500 slipped 0.18% and the Nasdaq 0.06%, that was outperformance.
Two design choices explain why the flood didn’t come. First, the release is staggered rather than instant: insiders can sell only the first 20% of eligible shares now, with further tranches lifting on Aug. 20 and again in late September. Second, a separate tranche stays frozen entirely because the stock is trading below its $135 IPO price — a price-conditional gate that, ironically, the slide itself slammed shut.
Our take: Everyone modelled the unlock as a supply shock. The more durable effect is mechanical demand. Index providers weight constituents by float-adjusted market cap, and SpaceX’s float just went from under 5% to above 12%. That forces passive funds tracking those benchmarks to buy, on a schedule, regardless of what they think of AI capex. A lockup expiry is a one-week story about sellers and a multi-quarter story about who is structurally required to own the stock.
The other thing the float does
A 4.9% float is not a market, it is a keyhole. Scarcity was doing real work in SpaceX’s price for seven weeks: the stock ran from a $135 IPO to $225.64 on June 16, then gave back 49% from that peak. Thin floats amplify moves in both directions because there is almost nothing to absorb an order. Doubling the tradable base is what turns a scarcity-priced ticker into something closer to normal price discovery — less violent up, less violent down.
Sell-side opinion is still split down the middle on where that discovery lands. On Wednesday, Macquarie maintained Outperform with a $250 target, Wells Fargo stayed Overweight but cut to $215, and Piper Sandler sat at Neutral with a target of $140. The consensus average price forecast is $228.72 — roughly double where the stock trades. That gap is the whole argument: fundamentals largely unchanged, or a business whose capital intensity nobody had modelled properly.
What to watch
- Aug. 20 and late September. Each subsequent tranche is its own volatility event. The Thursday result is evidence about mechanics, not a guarantee for the next two.
- The $135 line. If the stock reclaims its IPO price, the price-conditional tranche unlocks and adds supply exactly when sentiment improves. That is a self-limiting rally.
- Index rebalance dates. The passive bid only shows up when providers refresh float factors. Watch the schedules, not the headlines.
- Insider Form 144 filings. Who actually sold in that first 20% tells you more than any survey of what insiders said they might do.
The lockup was supposed to be the test. It turned out to be the setup.